Deficiency of phosphofructo-1-kinase/muscle subtype in humans impairs insulin secretion and causes insulin resistance

Journal of Clinical Investigation

Volumn 100, Issue 11, 1997, Pages 2833-2841

  Ristow, Michael ^a,b   Vorgerd, Matthias ^a   Möhlig, Matthias ^a   Schatz, Helmut ^a   Pfeiffer, Andreas ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Diabetes genetics; Glycogenosis; Insulin secretion; Non insulin dependent diabetes mellitus; Phosphofructokinase

Indexed keywords

6 PHOSPHOFRUCTOKINASE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CLINICAL ARTICLE; DNA DETERMINATION; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; GLUCOSE METABOLISM; GLYCOGEN STORAGE DISEASE; GLYCOLYSIS; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; MALE; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN FAMILY;

EID: 0031442028     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119831     Document Type: Article

References (53)

1. Goldhammer, A.R., and H.H. Paradies. 1979. Phosphofructokinase: structure and function. Curr. Top. Cell. Regul. 15:109-141.
2. Dunaway, G..A., T.P. Kesten, T. Sebo, and R. Trapp. 1988. Analysis of the phosphofructokinase subunits and isoenzymes in human tissues. Biochem. J. 251:677-683.
3. Vora, S., M. Davidson, C. Seaman, A.F. Miranda, N.A. Noble, K.R. Tanaka, E.P. Frenkel, and S. DiMauro. 1983. Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency. J. Clin. Invest. 72:1995-2006.
4. Tarui, S., G. Okuno, and Y. Ikura. 1965. Phosphofructokinase deficiency in skeletal muscle. A new type of glycogenosis. Biochem. Biophys. Res. Commun. 19:517-523.
5. Layzer, R.B., L.P. Rowland, and H.M. Ranney. 1967. Muscle phosphofructokinase deficiency. Arch. Neurol. 17:512-523.
6. DiMauro, S., and S. Tsujino. 1994. Nonlysosomal glycogenoses. In Myology. A.G. Engel and B.Q. Banker, editors. McGraw-Hill Inc., New York. 1554-1576.
7. Sherman, J.B., N. Raben, C. Nicastri, Z. Argov, H. Nakajima, E.M. Adams, C.M. Eng, T.M. Cowan, and P.H. Plotz. 1994. Common mutation in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenosis VII - and their population frequency. Am. J. Hum. Genet. 55:305-313.
8. Randle, P.J. 1993. Glucokinase and candidate genes for type II (non-insulin dependent) diabetes mellitus. Diabetologia. 36:269-275.
9. DeFronzo, R.A., R.C. Bonadonna, and E. Ferrannini. 1992. Pathogenesis of NIDDM: a balanced overview. Diabetes Care. 15:318-368.
10. Kahn, C.R. 1994. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes. 43:1066-1084.
11. Groop, L.C., E. Widen, and E. Ferrannini. 1993. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or methods? Diabetologia. 36:1326-1331.
12. Taylor, S.I., D. Accili, and Y. Imai. 1994. Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes. 43:735-740.
13. Hales, C.N. 1994. The pathogenesis of NIDDM. Diabetologia. 37(Suppl. 2):S162-S168.
14. van Schaftingen, E. 1993. Glycolysis revisited. Diabetologia. 36:581-588.
15. Katz, A., M.K. Spencer, S. Lillioja, Z. Yan, D.M. Mott, R.G. Haller, and S.F. Lewis. 1991. Basal and insulin-mediated carbohydrate metabolism in human muscle deficient in phosphofructokinase 1. Am. J. Physiol. 261(Endocrinol. Metab. 24):E473-E478.
16. Haller, R.G., and S.F. Lewis. 1991. Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency. N. Engl. J. Med. 324:364-369.
17. Malaisse, W.J., F. Malaisse-Lagae, A. Sener, E. van Schaftingen, and H.G. Hers. 1981. Is the glucose-induced stimulation of glycolysis in pancreatic islets attributable to activation of phosphofructokinase by fructose 2,6-bisphosphate? FEBS (Fed. Eur. Biochem. Soc.) Lett. 125:217-219.
18. Perna, A.F., G.Z. Fadda, and S.O. Massry. 1991. Inhibition of phosphofructokinase activity in pancreatic islets in phosphate depletion. Miner. Electrolyte Metab. 17:8-11.
19. Zhou, X.J., G.Z. Fadda, A.F. Perna, and S.G. Massry. 1991. Phosphate depletion impairs insulin secretion by pancreatic islets. Kidney Int. 39:120-128.
20. Yaney, G.C., V. Schultz, B.A. Cunningham, G.A. Dunaway, B.E. Corkey, and K.A. Tornheim. 1995. Phosphofructokinase isoenzymes in pancreatic islets and clonal β cells (INS-1). Diabetes. 44:1285-1289.
21. Vorgerd, M., M. Ristow, E. van Schaftingen, M. Tegenthoff, F. Jerusalem, and J.P. Malin. 1996. Muscle phosphofructokinase deficiency in two generations. J. Neurol. Sci. 141:95-99.
22. Bonilla, E., and D.L. Schotland. 1970. Histochemical diagnosis of muscle phosphofructokinase deficiency. Arch. Neurol. 22:8-12.
23. Dubowitz, V. 1985. Muscle Biopsy: A Practical Approach. Bailliere Tindall Ltd., London.
24. DiMauro, S., C. Angelini, and C. Catani. 1967. Enzymes of the glycogen cycle and glycolysis in various human neuromuscular disorders. J. Neurol. Neurosurg. Psychiatry. 30:411-415.
25. Beutler, E., K.G. Blume, J.C. Kaplan, G.W. Löhr, B. Ramot, and W.N. Valentine. 1977. International Committee for Standardization in Haematology: recommended methods for red-cell enzyme analysis. Br. J. Haematol. 35:331-340.
26. Ausubel, F.M. 1993. Current Protocols in Molecular Biology. Harvard University Press, New York.
27. Ristow, M., M. Möhlig, M. Rifai, H. Schatz, K. Feldmann, and A. Pfeiffer. 1995. New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains. Lancet. 346:502-503.
28. Rayman, G., P. Clark, A.E. Schneider, and C.N. Hales. 1990. The first phase insulin response to intravenous glucose is highly reproducible. Diabetologia. 33:631-634.
29. Kruse-Jarres, J.D. 1979. Blutglucose-Biokinetik. Georg Thieme Verlag, Stuttgart, Germany. 72-74.
30. Pei, D., C.N.O. Jones, R. Bhargava, Y.D.I. Chen, and G.M. Reaven. 1994. Evaluation of octreotide to assess insulin-mediated glucose by the insulin suppression test. Diabetologia. 37:843-845.
31. Bauer, W., U. Briner, W. Doepfner, R. Haller, R. Huguenin, P. Marbach, T.J. Petcher, and J. Pless. 1982. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 31:1133-1140.
32. Greenfield, M.S., L. Doberne, F. Kraemer, T. Tobey, and G.M. Reaven. 1981. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes. 30:387-392.
33. Mimura, A., S. Kageyama, M. Maruyama, Y. Ikeda, and Y. Isogai. 1994. Insulin sensitivity test using a somatostatin analogue, octreotide. Horm. Metab. Res. 26:184-187.
34. Bartlett, D.L., S.L. Charland, and M.H. Torosian. 1995. Reversal of tumor-associated hyperglucagonemia as treatment for cancer cachexia. Surgery (St. Louis). 118:87-97.
35. Baule, G.M., D. Onorato, G. Tola, G. Forteloni, and T. Meloni. 1983. Hemoglobin A1 in subjects with G-6-PD deficiency during and after hemolytic crises due to favism. Acta Haematol. (Basel). 69:15-18.
36. Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat. Genet. 1: 368-371.
37. Chiu, K.C., M.A. Province, and M.A. Permutt. 1992. Glucokinase gene is a genetic marker for NIDDM in American blacks. Diabetes. 41:843-849.
38. Permutt, M.A., K.C. Chiu, and T. Yukio. 1992. Glucokinase and NIDDM: a candidate gene that paid off. Diabetes. 41:1367-1372.
39. Noda, K., A. Matsutani, Y. Tanizawa, R. Neuman, T. Kaneko, M.A. Permutt, and K. Kaku. 1993. Polymorphic microsatellite repeat markers at the glucokinase gene locus are positively associated with NIDDM in Japanese. Diabetes. 42:1147-1152.
40. Kadowaki, T., H. Sakura, S. Otabe, K. Yasuda, H. Kadowaki, Y. Mori, R. Hagura, Y. Akanuma, and Y. Yazaki. 1995. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. Muscle Nerve. 3:S137-S141.
41. 't Hart, L.M., H.H. Lemkes, R.J. Heine, R.P. Stolk, E.J. Feskens, J.J. Jansen, F.E. van der Does, D.E. Grobbee, D. Kromhout, J.M. van den Ouweland, and J.A. Maassen. 1994. Prevalence of maternally inherited diabetes and deafness in diabetic populations in the Netherlands. Diabetologia. 37:1169-1170.
42. Groop, L.C., M. Kankuri, C. Schalin-Jäntti, A. Ekstrand, P. Nikula-Ijas, E. Widen, E. Kuismanen, J. Eriksson, A. Franssila-Kallunki, and C. Saloranta. 1993. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 328:10-14.
43. Zouali, H., G. Velho, and P. Froguel. 1993. Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 328:1568.
44. Hager, J., L. Hansen, C. Vaisse, N. Vionnet, A. Philippi, W. Poller, G. Velho, C. Carcassi, L. Contu, C. Julier, and P. Froguel. 1995. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nat. Genet. 9:299-304.
45. DeFronzo, R.A. 1988. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 37:667-687.
46. Bogardus, C., S. Lillioja, B.V. Howard, G. Reaven, and D. Mott. 1984. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J. Clin. Invest. 74:1238-1246.
47. Ashcroft, F.M., and S.J.H. Ashcroft. 1992. Mechanism of insulin secretion. In Insulin: Molecular Biology to Pathology. F.M. Ashcroft, and S.J.H. Ashcroft, editors. IRL Press at Oxford University Press, Oxford. 97-150.
48. Crockford, P.M., R.J. Harbeck, and R.H. Williams. 1966. Influence of age on intravenous glucose tolerance and serum immunoreactive insulin. Lancet. 1:465-467.
49. Granner, D.K., and R.M. O'Brien. 1992. Molecular physiology and genetics of NIDDM. Diabetes Care. 15:369-395.
50. Brunzell, J.D., R.P. Robertson, R.L. Lerner, W.R. Hazzard, J.W. Ensinck, E.L. Bierman, and D. Porte, Jr. 1976. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J. Clin. Endocrinol. Metab. 42:222-229.
51. Temple, R.C., C.A. Carrington, S.D. Luzio, D.R. Owens, A.E. Schneider, W.J. Sobey, and C.N. Hales. 1989. Insulin deficiency in non-insulin-dependent diabetes. Lancet. 1:293-295.
52. Yoshioka, N., T. Kuzuya, A. Matsuda, M. Taniguchi, and Y. Iwamoto. 1988. Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 31:355-360.
53. McKusick, V.A. 1997. Glycogen storage disease VII. Online Mendelian Inheritance In Man (http://www3.ncbi.nlm.nih.gov:80/htbin-post/Omim/dispmim?232800).